Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
10/26/2012 | WO2012145535A2 Animal model of human cancer and methods of use |
10/26/2012 | WO2012145514A2 Compositions and methods for genotyping ces1 genetic variants and use thereof |
10/26/2012 | WO2012145459A2 Glucose and insulin sensors and methods of use thereof |
10/26/2012 | WO2012145449A1 Methods and devices for amplifying nucleic acids |
10/26/2012 | WO2012145399A2 Methods of diagnosing cancer in a patient |
10/26/2012 | WO2012145382A2 Measurement of pka for cancer characterization |
10/26/2012 | WO2012145363A1 METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD) |
10/26/2012 | WO2012145129A2 Molecular subtyping, prognosis and treatment of prostate cancer |
10/26/2012 | WO2012145019A1 Methods for isolating a target analyte from a hetherogeneous sample |
10/26/2012 | WO2012144826A2 System for detecting biomolecule interaction, and detection method using same |
10/26/2012 | WO2012144755A2 Composition and kit for the diagnosis of mild cognitive impairment, which measure an expression level of lipocalin-2, and method for providing information for the diagnosis of mild cognitive impairment |
10/26/2012 | WO2012144554A1 Method and kit for assessing virus concentration |
10/26/2012 | WO2012144512A1 Use of myelin basic protein as a novel genetic factor for rheumatoid arthritis |
10/26/2012 | WO2012144485A1 Method for detecting nucleic acid molecule in biosample |
10/26/2012 | WO2012144220A1 Ezh2 as target gene for cancer therapy and diagnosis |
10/26/2012 | WO2012143696A1 Obtaining plants of atypical ploidy or zygosity |
10/26/2012 | WO2012143661A1 Method for quantifying living bacteria in a liquid medium |
10/26/2012 | WO2012143647A1 Methods for detecting contaminants in solutions containing glucose polymers |
10/26/2012 | WO2012143534A2 Method for detecting at least one cephalosporin resistance mechanism by means of mass spectrometry |
10/26/2012 | WO2012143481A2 Prostate cancer markers |
10/26/2012 | WO2012143010A1 New method for enzyme-mediated signal amplification |
10/26/2012 | WO2012142924A1 METHOD AND PRIMERS FOR DETECTION OF miRNA, AND APPLICATION THEREOF |
10/26/2012 | WO2012142666A1 Method of modulating amine oxidase activity and agents useful for same |
10/26/2012 | WO2012142656A1 Method of diagnosing cancer |
10/26/2012 | WO2012112884A3 Real-time pcr point mutation assays for detecting hiv - 1 resistance to antiviral drugs |
10/26/2012 | WO2012106469A3 Methods for treating infections by targeting microbial h2s-producing enzymes |
10/26/2012 | WO2012103174A3 Iris control system for conducting the identification of bacteria in biological samples |
10/26/2012 | WO2012102773A3 Cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity |
10/26/2012 | WO2012094492A3 Combinatorial dna taggants and methods of preparation and use thereof |
10/26/2012 | WO2012094459A3 Assay cartridges and methods of using the same |
10/26/2012 | WO2012089742A3 IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS |
10/26/2012 | WO2012088268A3 Modulators for sirt6 and assays for screening same |
10/26/2012 | WO2012084173A3 Methods and compositions for detecting mutation in the human epidermal growth factor receptor gene |
10/26/2012 | WO2012083069A3 Measurement and monitoring of cell clonality |
10/26/2012 | WO2012039615A3 Commensal rat ileum bacterium (crib) |
10/26/2012 | WO2011163323A3 Modified carbonic anhydrase enzymes and their use in carbon dioxide sequestration and elimination |
10/26/2012 | CA2856304A1 Oscillating amplification reaction for nucleic acids |
10/26/2012 | CA2853615A1 Integrated device for nucleic acid detection and identification |
10/26/2012 | CA2833534A1 Molecular subtyping, prognosis and treatment of prostate cancer |
10/26/2012 | CA2833454A1 Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry |
10/26/2012 | CA2833389A1 Mirna-based universal screening test (ust) |
10/26/2012 | CA2833375A1 Methods of using mirna from bodily fluids for early detection and monitoring of mild cognitive impairment (mci) and alzheimer's disease (ad) |
10/26/2012 | CA2832907A1 New method for enzyme-mediated signal amplification |
10/26/2012 | CA2831003A1 Methods for detecting contaminants in solutions containing glucose polymers |
10/25/2012 | US20120272347 Chitosan-alginate scaffold cell culture system and related methods |
10/25/2012 | US20120272345 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis |
10/25/2012 | US20120272343 Stromal interacting molecule knockout mouse and uses thereof |
10/25/2012 | US20120272342 Mouse artificial chromosome vector |
10/25/2012 | US20120272341 Novel gene disruptions, compositions and methods relating thereto |
10/25/2012 | US20120271794 Method for managing treatment of a patient health condition with a pda based system |
10/25/2012 | US20120271035 T1r taste receptors and genes encoding same |
10/25/2012 | US20120270948 Polymorphisims in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
10/25/2012 | US20120270947 Short Telomere Length on Chromosome 9P is Strongly Associated with Breast Cancer Risk |
10/25/2012 | US20120270930 Methods and compositions for dysferlin exon-skipping |
10/25/2012 | US20120270923 Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer |
10/25/2012 | US20120270914 Split-luciferase c-myc sensor and uses thereof |
10/25/2012 | US20120270890 Methods of Pancreatic Beta Cell Regeneration |
10/25/2012 | US20120270836 Therapeutic approaches for treating alzheimer's disease |
10/25/2012 | US20120270812 Compositions, methods, and kits for determining an alkyl transferase |
10/25/2012 | US20120270809 Human transmembrane proteins |
10/25/2012 | US20120270806 Designer Cyclic Peptides - HIV gp120 Antagonists and their Applications |
10/25/2012 | US20120270799 METHOD OF IDENTIFYING A CANDIDATE COMPOUND WHICH MAY INHIBIT a9-nAchR OVEREXPRESSION OR ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN NICOTINE-DERIVED-COMPOUND-INDUCED BREAST CANCER CELLS |
10/25/2012 | US20120270794 Polymorphisms associated with parkinson's disease |
10/25/2012 | US20120270792 Urocortin-iii and uses thereof |
10/25/2012 | US20120270773 Trim5alpha mutants and uses thereof |
10/25/2012 | US20120270757 Site-specific labeling of affinity tags in fusion proteins |
10/25/2012 | US20120270750 Microarray Synthesis and Assembly of Gene-Length Polynucleotides |
10/25/2012 | US20120270749 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
10/25/2012 | US20120270747 Method of predicting risk of pre-term birth |
10/25/2012 | US20120270746 Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent |
10/25/2012 | US20120270744 Methods to determine if a subject will respond to a bcr-abl inhibitor |
10/25/2012 | US20120270742 Obesity Dependent Adipokine Biomarkers for Prostate Cancer |
10/25/2012 | US20120270740 Polony sequencing methods |
10/25/2012 | US20120270316 Methods and reagents for preserving rna in cell and tissue s amples |
10/25/2012 | US20120270301 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
10/25/2012 | US20120270272 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
10/25/2012 | US20120270261 Analytical instrument and method for evaluating microbial contamination of an object |
10/25/2012 | US20120270260 Methods of developing terpene synthase variants |
10/25/2012 | US20120270259 Fish cancer model |
10/25/2012 | US20120270254 Method for analyzing secretome, biomarker for lung cancer metastasis, and sirna compound for inhibiting lung cancer metastasis |
10/25/2012 | US20120270253 Method For Preparing Maltogenic Alpha-Amylase Variants |
10/25/2012 | US20120270252 Medium for the specific detection of resistant microorganisms |
10/25/2012 | US20120270251 Inhibition of the activity of kinase and synthetase enzymes |
10/25/2012 | US20120270250 Test system for measuring mest activity as well as methods and uses involving the same |
10/25/2012 | US20120270249 Medium for the specific detection of resistant microorganisms |
10/25/2012 | US20120270248 Detection of bacteria in biological fluids |
10/25/2012 | US20120270234 Ddr2 protein with activated kinase activity and preparation method thereof |
10/25/2012 | US20120270233 Association of biomarkers with patient outcome |
10/25/2012 | US20120270229 Device for detection of analytes and uses thereof |
10/25/2012 | US20120270228 Predictors of patient response to treatment with egf receptor inhibitors |
10/25/2012 | US20120270227 Glycine n-methyltransferase (gnmt) animal model and use thereof |
10/25/2012 | US20120270226 matching of forensic results |
10/25/2012 | US20120270225 Device and apparatus |
10/25/2012 | US20120270224 Method for accurate assessment of dna quality after bisulfite treatment |
10/25/2012 | US20120270223 Oligonucleotide sequences that identify species of animal |
10/25/2012 | US20120270222 Method for the Efficiency-Corrected Real-Time Quantification of Nucleic Acids |
10/25/2012 | US20120270220 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
10/25/2012 | US20120270219 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
10/25/2012 | US20120270218 Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer |
10/25/2012 | US20120270217 Restriction endonuclease enhanced polymorphic sequence detection |